Bausch Health Companies (BHC) Non Operating Income (2016)

Bausch Health Companies' (BHC) quarterly Non Operating Income came in at -$22.0 million in Q4 2016.

Bausch Health Companies (BHC) Non Operating Income (2016) Analysis & Trends

Bausch Health Companies has disclosed Non Operating Income across 1 years of filings, most recently posting -$22.0 million for Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -216.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 20.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -7.50 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -504,111.66
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 53.40 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -13.65 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 5.71 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -23.23 Mn
10 Bausch Health Companies 1.91 Bn 1.58 Bn 2.48 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2016 -22.00 Mn